Skip to main content

Table 8 Changes in intermediate patient outcomes°

From: Effectiveness of the introduction of a Chronic Care Model-based program for type 2 diabetes in Belgium

  Intervention period Δ
01/01/04-01/01/07 		P value*
  01/01/2004 01/01/2007   
HbA1c (%)     
   Intervention 7.55(7.48-7.62) 7.06(7.00-7.12) -0.49(p < 0.0001) 0.4207
   Control 7.44(7.34-7.53) 6.90(6.83-6.98) -0.54(p < 0.0001)  
TC (mg/dl)     
   Intervention 199.07(197.01-201.13) 173.94(171.85-176.04) -25.13(p < 0.0001) 0.0021 (1)
   Control 199.44(197.03-201.90) 180.60(177.83-183.41) -18.84(p < 0.0001)  
  1. °linear mixed model; Δ = evolution; *P value for the evolution between the intervention and control region, (1) significantly greater change in the intervention region (2) significantly greater change in the control region
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us